2015 LCRMP Workshop Provides Eight Early Career Clinicians with Career and Research Mentoring

The second class of the Lymphoma Research Foundation's (LRF) Clinical Research Mentoring Program (LCRMP) convened for the 2015 LCRMP Workshop on February 24-28 in Scottsdale, Arizona. The LCRMP is an education and mentoring program for fellows and junior faculty with a focus in clinical research in the field of non-Hodgkin and Hodgkin lymphoma. Program participants, called LRF Scholars, attend and participate in intensive introductory workshop and follow-up programming intended to enhance the ability of the LRF Scholars to successfully design and administer clinical research studies and successfully apply for future grant funding. Scholars also receive a grant of $10,000 total over two years to support professional development expenses such as travel to conferences, tuition, and equipment.

Individual profiles of the 2015 LRF Scholars and their Workshop projects are linked below. For more on the LCRMP Workshop and program, see the Spring 2015 Research Report.

Danielle Brander, MD of Duke University Medical Center
Phase I Trial of Ibrutinib plus a PI3K gamma/delta dual inhibitor in Relapsed/Refractory B-cell NHL

Carla Casulo, MD of University of Rochester
Biologic Characterization of High Risk Follicular Lymphoma

Solomon Graf, MD of University of Washington
A phase II pilot window study of ixazomib (MLN9708) in untreated B-cell malignancies

Reem Karmali, MD of Rush University Medical Center
Impact of Cachexia on Clinical Outcomes in Aggressive Lymphomas

David Kurtz, MD of Stanford University
Circulating tumor DNA dynamics for rapid assessment of therapeutic response in non-Hodgkin lymphoma

Craig Portell, MD of University of Virginia
Multi-institution Phase I/Ib study of ibrutinib with ABT-199 in relapsed/refractory MCL

Jason Westin, MD of University of Texas MD Anderson Cancer Center
Creation of The Diffuse Large B-cell Lymphoma Response Prediction Model

Victor Yazbeck, MD of Virginia Commonwealth University Massey Cancer Center
Phase I trial of panobinostat plus buparlisib in patients with relapsed or refractory lymphoma

Applications for the 2016 LCRMP Workshop will open in June. Email to be added to the grant announcement list.

To learn more about the LRF research program, or the research and investigators supported by the Foundation please click here.

To read about other Featured LRF Researchers, click here.